The results indicated that a reduction in Nogo levels led to a protective effect against HFD-induced obesity, reversed whitening of brown adipose tissue, and an attenuation of inflammatory responses in organs due to enhanced NF-κB p65 degradation via the lysosome pathway. The gene discussed is NFKB1; the disease is Obesity.